Quantum-Si incorporated (QSI)
| Market Cap | 232.59M |
| Revenue (ttm) | 3.06M |
| Net Income (ttm) | -101.01M |
| Shares Out | 183.14M |
| EPS (ttm) | -0.71 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 3,114,375 |
| Open | 1.300 |
| Previous Close | 1.310 |
| Day's Range | 1.250 - 1.330 |
| 52-Week Range | 0.612 - 5.770 |
| Beta | 2.79 |
| Analysts | Strong Buy |
| Price Target | 3.42 (+169.29%) |
| Earnings Date | Mar 3, 2025 |
About QSI
Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company offers Platinum NGPS instrument that provides single molecule amino acid level resolution with a streamlined workflow, including automated data analysis that accessible to researchers in all laboratory types; Platinum Pro NGPS instrument, a single molecule amino acid resolution, which provides an enhanced user interface, cloud or on instrument data analysis and an ava... [Read more]
Financial Performance
In 2024, Quantum-Si incorporated's revenue was $3.06 million, an increase of 182.62% compared to the previous year's $1.08 million. Losses were -$101.01 million, 5.26% more than in 2023.
Financial StatementsAnalyst Forecast
According to 3 analysts, the average rating for QSI stock is "Strong Buy." The 12-month stock price forecast is $3.42, which is an increase of 169.29% from the latest price.
News
Quantum-Si Begins Shipping Platinum® Pro, Advancing Accessibility in Next-Gen Protein Sequencing™
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Begins Shipping Platinum® Pro, Advancing Accessibility in Next-Gen Protein Sequencing™.
Quantum-Si to Participate in DNAnexus Webinar on Large Scale Proteomics in Multi-Omics Research
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si to participate in DNAnexus webinar on large scale proteomics in multi-omics research.
Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4).
Quantum-Si: A Rose, By Any Other Name, Wouldn't Smell As Sweet
Quantum-Si aims to revolutionize protein sequencing but faces significant technological and competitive challenges. Commercial reception to Quantum-Si's solutions has been lukewarm so far, suggesting ...
Quantum-Si incorporated (QSI) Q4 2024 Earnings Call Transcript
Quantum-Si incorporated (NASDAQ:QSI) Q4 2024 Earnings Conference Call March 3, 2025 4:30 PM ET Company Participants Katherine Atkins - SVP, Commercial Markets Jeff Hawkins - President and CEO Jeff Ke...
Quantum-Si Reports Fourth Quarter and Full Year 2024 Financial Results
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Reports Fourth Quarter and Full Year 2024 Financial Results.
Quantum-Si's Customers and Researchers to Showcase Next-Generation Protein Sequencing™ at AGBT 2025
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si's Customers and Researchers to Showcase Next-Generation Protein Sequencing™ at AGBT 2025.
Quantum-Si and Researchers to Showcase Next-Generation Protein Sequencing™ at US HUPO 2025
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si and Researchers to Showcase Next-Generation Protein Sequencing™ at US HUPO 2025.
Quantum-Si to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025.
Quantum-Si Establishes Scientific Advisory Board to Shape Next-Generation Proteomic Technologies
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Establishes Scientific Advisory Board to Shape Next-Generation Proteomic Technologies.
Quantum-Si and IDEX Health & Science to Partner on Optics Module for Proteus™ Instrument
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si and IDEX Health & Science to Partner on Optics Module for Proteus™ Instrument.
Quantum-Si Showcases Advances in Multiomics at the Festival of Genomics UK
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Showcases Advances in Multiomics at the Festival of Genomics UK.
Quantum-Si Launches Platinum® Pro: The End-to-End Solution for Deeper Insights in Proteomics
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Launches Platinum® Pro: The End-to-End Solution for Deeper Insights in Proteomics.
Quantum-Si's New Preprint Showcases Protein Barcoding as a Powerful Tool for Transforming Proteomics
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si's New Preprint Showcases Protein Barcoding as a Powerful Tool for Transforming Proteomics.
Quantum-Si's 327% Rally In Six Months: Is Nvidia The Catalyst For More Gains?
Quantum-Si Inc. QSI is stealing the biotech spotlight with a jaw-dropping 327% surge over the past six months. The proteomics pioneer's stock now sits at $4.10, boasting a strong bullish trend and cat...
Quantum-Si Incorporated Announces Pricing of $50 Million Registered Direct Offering of Common Stock
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated Announces Pricing of $50 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules.
Quantum-Si: The Technical Picture Has Improved (Rating Upgrade)
Since my last article, QSI's technical picture has improved, meeting all my investment criteria: bullish price action, momentum, volume, and relative strength. QSI is now above its upward sloping 30-w...
RGTI, QSI, QMCO, IONQ stocks are surging: time to short them?
Quantum computing stocks have gone parabolic this month as investors pile into this sector, comparing it to the artificial intelligence industry. Rigetti Computing (RGTI) stock has soared by over 542...
Quantum-Si's New Preprint Showcases Advances in Protein Variant Detection using ProteoVue™ Software with Next-Generation Protein Sequencing™
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced a new paper that was submitted to BioRx...
Quantum-Si Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4).
Quantum-Si Expands International Distribution Network
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Expands International Distribution Network.
Quantum-Si Launches Platinum® New Library Prep Kit, Expanding Access to Next-Generation Protein Sequencing™
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Launches Platinum® New Library Prep Kit, Expanding Access to Next-Generation Protein Sequencing™.
Quantum-Si Introduces Protein Barcoding Kit for Multiplexed Protein Screening
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Introduces Protein Barcoding Kit for Multiplexed Protein Screening.
Quantum-Si Highlights Major Technical Advances, Next-Generation Platform Architecture and New Proteomic Applications at Investor & Analyst Event
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced the highlights of an Investor & Analyst...
Nvidia Partners With Quantum-Si To Advance Single-Molecule Analysis
On Wednesday, Quantum-Si Incorporated QSI stock traded over 100% higher after the protein sequencing company announced a collaboration with NVIDIA Corporation NVDA to develop its new proteomics platfo...